Life Science News

RSS

Evolutionary changes in key enzyme help bacteria fine-tune protein synthesis

Evolutionary changes in key protein synthesis enzyme, isoleucyl-tRNA synthetase (IleRS), may help bacteria fine-tune how quickly proteins are made, report researchers from Institute of Science Tokyo, Japan; the University of Zagreb Faculty of Science, Croatia; and ETH Zürich, Switzerland.

29 Oct 2026

New study identifies potential targets for KRAS-related treatment resistance

Decoding of messenger RNA (mRNA) occurs during translation, the vital cellular process that builds proteins. Errors in this process are known to lead to cancer growth.

29 Oct 2026

Understanding the mechanisms of multilineage coordination during craniofacial development

The human face is one of the most complex structures formed during embryonic development. Its formation requires different cell populations to produce bones, muscles, nerves, blood vessels, teeth, and glands, all arranged in the correct positions and connected to perform their functions.

29 Oct 2026

Large genetic study uncovers new risk factors for Alzheimer's

A large-scale international study, led by Ole Andreassen at University of Oslo and Oslo University Hospital, in collaboration with international consortium, offers new insights for understanding the disease and developing future treatments.

29 Oct 2026

New mathematical method maps gene roles across different species

Much of what we know about biology comes from animal models, particularly mice. Applying these insights to humans, however, is not always straightforward.

29 Oct 2026

Revvity launches Signals LabGistics solution to connect and orchestrate scientific workflows

Revvity, Inc. announced that its Revvity Signals Software business is launching the Signals LabGistics™ solution, an AI-first, scientific workflow orchestration solution designed to connect and coordinate processes, workflows, and tasks from discovery to manufacturing.

From Revvity Signals Software Inc. 29 Oct 2026

Novel transporter protein discovery opens new pathways for central nervous system therapies

Researchers at the University of Eastern Finland have identified a transporter protein with the potential to open new avenues for improving creatine delivery into the brain and for developing other therapies targeting the central nervous system.

29 Oct 2026

Insights into enzyme selectivity open new pathways for pharmaceutical synthesis

Enzymes are the molecular tools of life. They accelerate chemical reactions and are able to distinguish very precisely between molecules that are similar to one another. The high selectivity of many enzymes is key to the production of important medicines such as penicillin and cyclosporine. But how did enzymes develop this ability to distinguish between similar chemical functionalities with such precision.

29 Oct 2026

Ancient protein model shows early steps in energy metabolism

Researchers in Japan engineered ancestral nucleoside diphosphate kinase variants with restricted amino acid repertoires to explore alternative catalytic functions. One variant, Arc1-12KR, retained its protein fold despite lacking catalytic histidine and unexpectedly converted two ADP molecules into ATP and AMP. The findings reveal alternative catalytic potential in simplified proteins and offer clues to possible routes of energy metabolism during early protein evolution.

29 Oct 2026

ATCC selected by ARPA-H to support next-generation BioStabilization technologies

ATCC has been selected by the Advanced Research Projects Agency for Health (ARPA-H) as an affiliate to provide independent verification and validation (IV&V) for its BioStabilization Systems (BoSS) program.

From ATCC 29 Oct 2026

New microscopy platform enables deeper brain imaging without tissue damage

As light travels deeper into the brain, it scatters. Three-photon microscopy, the current state of the art, reduces the resulting background fluorescence and can, in principle, image much deeper than earlier techniques-but to do that, it uses average laser power limits that cause overheating and damage living tissue.

28 Oct 2026

COMPASS pathway helps regulatory T cells prevent intestinal inflammation

Trillions of bacteria live in the human gut without triggering an immune response. Scientists at St. Jude Children's Research Hospital have now discovered a gene-regulatory pathway that helps maintain this delicate balance.

28 Oct 2026

High-fat diets in mouse parents alter offspring brain development

Researchers fed breeding pairs of mice five diets with different fat and sugar contents to examine how parental nutrition affects offspring brain development. High-fat diets, alone or combined with high sugar, delayed early motor development and altered brain structure in young adult offspring, while the high-sugar-only diet produced no significant changes in individual brain regions after correction for multiple comparisons.

28 Oct 2026

Landmark studies map how genetic differences drive human diseases

In three landmark studies published in Nature today, Australian researchers have made major advances in our understanding of how genetic differences between people influence disease.

28 Oct 2026

Japan's new law advances reproductive genome editing governance

A Hiroshima University researcher outlines advantages of Japan's new law that prohibits the transfer of genome-edited human embryos or germ cells into the human reproductive tract and imposes criminal penalties for violations.

28 Oct 2026

Macromolecular crowding helps control synthetic DNA droplet formation

Macromolecular crowding can serve as a design tool for controlling the formation and organization of synthetic DNA droplets, a study from Science Tokyo reveals.

28 Oct 2026

DEBRA research invests in Topadur to advance small-molecule therapies for dystrophic Epidermolysis bullosa

DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug development for Epidermolysis bullosa (EB), and Topadur Pharma AG, a Swiss clinical-stage biopharmaceutical company, today announced an investment by DEBRA Research in Topadur to support a preclinical program exploring a new treatment approach for dystrophic Epidermolysis bullosa (DEB). DEB is one of the more severe forms of EB, characterized by extremely fragile skin and progressive, debilitating complications.

28 Oct 2026

Prolific announces major new investments and partnerships with NantWorks and Zylidac Bio CDMO

On the heels of our exciting major investment and Nantworks partnership announcement last week, Prolific Machines is pleased to announce a great new partnership with Zylidac Bio, a fully integrated biologics CDMO located next door to us in San Francisco Bay Area, to scale up the production of Prolific's Optogentics-enabled cell lines for clinical and GMP manufacturing!

From Prolific Machines, Inc. 28 Oct 2026

Atelerix and Frontier Space partner to enable biological sample preservation for space missions

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced a partnership with Frontier Space, a UK based space biotechnology company building platform technology for in-orbit R&D and biomanufacturing.

From Atelerix Ltd 28 Oct 2026

Novel peptide from red alga shows potential for blood glucose control

It is a dietary staple found in sushi, rice wraps, and ramen toppings. Commonly known as nori in Japan and gim in Korea, red seaweed is especially popular across Asia.

27 Oct 2026